{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34341531",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "08",
        "Day": "02"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41556-021-00721-x"
    ],
    "Journal": {
      "ISSN": "1476-4679",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Nature cell biology",
      "ISOAbbreviation": "Nat Cell Biol"
    },
    "ArticleTitle": "Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids.",
    "Pagination": {
      "StartPage": "822",
      "EndPage": "833",
      "MedlinePgn": "822-833"
    },
    "Abstract": {
      "AbstractText": [
        "Clinical management of patients with severe complications of COVID-19 has been hindered by a lack of effective drugs and a failure to capture the extensive heterogeneity of the disease with conventional methods. Here we review the emerging roles of complex organoids in the study of SARS-CoV-2 infection, modelling of COVID-19 disease pathology and in drug, antibody and vaccine development. We discuss opportunities for COVID-19 research and remaining challenges in the application of organoids."
      ],
      "CopyrightInformation": "\u00a9 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-2983-6330"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. cheng@mail.nih.gov."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Kevin G",
        "Initials": "KG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA."
          }
        ],
        "LastName": "Park",
        "ForeName": "Kyeyoon",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, MI, USA."
          }
        ],
        "LastName": "Spence",
        "ForeName": "Jason R",
        "Initials": "JR"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HL119215",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, N.I.H., Intramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Cell Biol",
    "NlmUniqueID": "100890575",
    "ISSNLinking": "1465-7392"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology",
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Organoids"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "COMPETING INTERESTS. The authors declare no competing interests."
}